Amrize (NYSE:AMRZ) was upgraded by analysts at
Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Amrize (NYSE:AMRZ) was given a new $58.00 price target on by analysts at The Goldman Sachs Group, Inc..
Amrize (NYSE:AMRZ) had its price target raised by analysts at UBS Group AG from $53.00 to $57.00. They now have a "neutral" rating on the stock.
Amrize (NYSE:AMRZ) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Amrize to Acquire PB Materials; Aggregates Leader in High-Growth West Texas